Market Overview - On August 19, the Hong Kong stock market showed a lack of direction for two consecutive days, with the Hang Seng Index falling by 54 points or 0.2% to close at 25,122 points. The Hang Seng Tech Index decreased by 0.7% to 5,542 points. The total market turnover reached HKD 278.2 billion, with a net inflow of HKD 18.57 billion into the Hong Kong Stock Connect, primarily into index ETFs [1] Interest Rates and Liquidity - The one-month HIBOR has risen to 2.57%, a two-month high, as the Hong Kong Monetary Authority continues to withdraw HKD liquidity. The Hong Kong-US interest rate spread has narrowed to 1.76%, leading to a strengthening of the Hong Kong dollar. The rising cost of funds in Hong Kong directly impacts corporate financing and investors' margin borrowing costs, potentially reducing the willingness to use leverage [2] - In the medium term, global liquidity is expected to ease, and if the Federal Reserve resumes preventive rate cuts in September, the one-month HIBOR may rise to around 3% before likely reversing downward [2] Automotive Sector - In the automotive sector, Li Auto (9863 HK) reported a half-year vehicle delivery volume of 221,000 units, a year-on-year increase of 155%, with revenue of CNY 24.25 billion, up 174% year-on-year. The company achieved a gross margin of 14.1%, an increase of 13 percentage points year-on-year, and a net profit of CNY 30 million, marking its first profitable half-year. The management has raised the annual sales target to 580,000-650,000 units, a year-on-year increase of 97%-121% [3] Healthcare Sector - The Hang Seng Healthcare Index fell by 1.6%, attributed to a pullback after consecutive gains. Hansoh Pharmaceutical (3692 HK) exceeded market expectations, with a year-on-year revenue increase of 14.3% and a net profit increase of 15.0%. The company's innovative drug product revenue grew rapidly, contributing to a 13.2% increase in total product sales revenue. The sales expense ratio and management expense ratio both decreased, leading to better-than-expected performance [4] Real Estate Sector - The transaction volume of new homes in 30 major cities reached 1.23 million square meters, a year-on-year decline of 15.5%, which is worse than the previous week's decline of 12.3%. The cumulative transaction volume in first-tier cities showed a slight narrowing of declines, with Beijing down 5.4%, Shanghai down 1.5%, Guangzhou up 12.4%, and Shenzhen up 6.3% [5][6] - The inventory-to-sales ratio for commodity housing in ten major cities rose to 121.5, higher than the previous year's 98.7 and the prior week's 119.0 [7] - The land transaction volume in 100 major cities fell by 66.4% year-on-year, with a total area of 7.35 million square meters [8] - Various supportive measures for the real estate market have been introduced across multiple regions, including new initiatives in Tianjin and Fuzhou [9] Policy Outlook - The National Bureau of Statistics reported disappointing figures for July, with new housing starts and completed projects down 15.2% and 29.5% year-on-year, respectively. The overall performance of the real estate market remains weak, but recent policy measures may provide some support [10][12]

Investment Rating - The report maintains a positive outlook on the real estate sector, particularly favoring quality state-owned and local state-owned developers [8][45]. Core Insights - The new housing transaction volume in 30 major cities reached 1.23 million square meters, a year-on-year decline of 15.5%, which is worse than the previous week's decline of 12.3% [1][15]. - The cumulative transaction volume of new homes in Beijing for the year so far is 3.25 million square meters, down 5.4% year-on-year, slightly better than the previous week's decline of 5.6% [2][18]. - The land transaction volume in 100 major cities fell to 7.35 million square meters, a year-on-year decrease of 66.4% [4][33]. - The ratio of inventory to sales for commercial housing in major cities increased to 121.5, up from 98.7 a year ago [3][27]. Summary by Sections New Housing Transactions - The new housing transaction volume in 30 major cities was 1.23 million square meters, down 15.5% year-on-year and down 4.9% month-on-month [1][15]. - The year-on-year changes for first, second, and third-tier cities were -26.8%, -12.1%, and -4.9% respectively [1][15]. Cumulative Transactions in Major Cities - Beijing's cumulative transaction volume for new homes is 3.25 million square meters, down 5.4% year-on-year [2][18]. - Shanghai's cumulative volume is 6.71 million square meters, down 1.5% year-on-year [2][18]. - Guangzhou's cumulative volume is 4.51 million square meters, up 12.4% year-on-year [2][18]. - Shenzhen's cumulative volume is 1.81 million square meters, up 6.3% year-on-year [2][18]. Land Transactions - The land transaction volume in 100 major cities was 7.35 million square meters, down 66.4% year-on-year and down 66.8% month-on-month [4][33]. - First-tier cities saw a 52.0% year-on-year decline in land transaction volume [4][33]. Policy Support Measures - Various regions have introduced supportive measures for the real estate market, including adjustments to housing fund withdrawal policies [5][40]. - The government is expected to continue implementing strong measures to stabilize the real estate market [8][45]. Market Performance - The Hang Seng China Mainland Property Index rose 5.3% last week, outperforming the broader Hang Seng Index by 3.6 percentage points [7][43]. - The report highlights specific stocks to watch, including China Resources Land (1109 HK) and Yuexiu Property (123 HK) [9][46].

Market Overview - On August 18, despite a lack of direction in the Hong Kong stock market, individual stocks showed good performance, with the Hang Seng Index down 93 points or 0.4% to close at 25,176 points, while the Hang Seng Tech Index rose 0.7% to 5,579 points [1] - The market saw a trading volume exceeding 311.9 billion HKD, indicating active trading. Net inflow from the Stock Connect decreased to 870 million HKD [1] - The overall market performance was stable, with 959 stocks rising, highlighting increased investor interest in high-performing stocks and industry leaders [1] Economic Analysis - Since July, the momentum of economic recovery in China has weakened, and the Hang Seng Index's valuation has significantly recovered, with a forecasted PE of approximately 11 times, returning to levels seen in 2018-2019 [2] - The risk premium is at a historical low, and the AH premium has reached a near six-year low. A technical correction in the index is considered a normal phenomenon within a high-level fluctuation [2] - The ample liquidity in the market supports Hong Kong stocks, while the 10-year Chinese government bond yield has risen to 1.78%, indicating a shift towards asset rebalancing from bonds to stocks [2] Real Estate Sector - The new housing transaction volume continued to decline year-on-year, with a reported 1.23 million square meters sold in 30 major cities, down 15.5% year-on-year [3] - The decline in transaction volume was worse than the previous week's 12.3% drop, with a month-on-month decrease of 4.9% [3] Industry Dynamics Consumer Sector - 361 Degrees (1361 HK) announced a strategic partnership with Stand Robot, focusing on wearable robots and high-performance materials, which positively impacted its stock price, rising 2.3% [4] Automotive Sector - The automotive sector saw a rally, with Great Wall Motors (2333 HK) rising 10.2%, driven by favorable sales and performance news [4] - Other automotive stocks like Geely (175 HK) and BYD (1211 HK) also saw increases of 2.6% and 0.8%, respectively [4] Innovative Pharmaceuticals - The innovative drug sector saw most major companies rise, with a focus on expanding medical insurance coverage and supporting pharmaceutical innovation [5] - China Biopharmaceutical (1177 HK) reported steady growth in the first half of the year, while Haijia Medical (6078 HK) forecasted a decline in revenue and net profit but improved cash flow due to reduced receivables [5] New Energy and Utilities - The new energy and utilities sector experienced narrow fluctuations, with some stocks like Harbin Electric (1133 HK) and Weisheng Holdings (3393 HK) rising by 1.3% and 4.5%, respectively [6] - Hong Kong and China Gas (1083 HK) reported expected mid-term results but saw a decline of 7.2% in stock price, possibly due to profit-taking [6] Company-Specific Updates China Water Affairs (855 HK) - The company announced an increase in water prices for a new supply project in Hubei, with price hikes of 9.6% to 64.4% effective from September 1 [7] - Two additional water supply projects are entering the hearing stage, with a total daily supply capacity of 104,000 tons [8] - The likelihood of a full acquisition offer for Kangda Environmental (6136 HK) is low, and it is not expected to impact the company's financial status [9] - The target price for China Water Affairs has been raised to 6.90 HKD, reflecting a potential upside of 11.1% [10] 361 Degrees (1361 HK) - The company reported a revenue increase of 11.0% to 5.71 billion RMB in the first half of the year, with a net profit of 860 million RMB, also up 8.6% [12] - The children's clothing segment showed strong performance, with a 25.8% increase in sales [13] - E-commerce revenue grew by 45% to 1.82 billion RMB, driven by promotional events and new product launches [14] - The target price for 361 Degrees has been adjusted to 7.74 HKD, corresponding to a 10 times FY26E PE ratio [15]

Market Performance - The Hang Seng Index rose 1.7% last week, closing at 25,270 points[1] - The Hang Seng Tech Index increased by 1.5%, ending at 5,543 points[1] - Average daily trading volume in Hong Kong stocks increased by 8.2% to HKD 242.8 billion[1] Capital Flows - Net inflow through the Hong Kong Stock Connect reached HKD 38.12 billion last week, with a record single-day inflow of HKD 35.88 billion on Friday[1] - Cumulative net inflow into Hong Kong stocks over the past 20 days amounted to HKD 159 billion, indicating strong market sentiment[1] Economic Indicators - In July, the US CPI showed a moderate inflation slowdown, with a probability of a 25 basis point rate cut by the Federal Reserve exceeding 90%[2] - China's economic indicators showed a marginal slowdown, with July's consumption, investment, production, and credit data all falling short of expectations[2] Real Estate Sector - Real estate development investment in China fell by 17.1% year-on-year in July, a larger decline than June's 12.4%[3] - New housing starts and completions dropped by 15.2% and 29.5% year-on-year, respectively, both exceeding June's declines[3] Industry Highlights - The automotive sector saw significant stock price increases, with Great Wall Motors rising 12.9% and Geely Auto up 4.5% last week[4] - The healthcare index surged by 7.1%, driven by strong performance from companies like Fosun Pharma, which saw an 8.7% increase in stock price[5] Renewable Energy - The photovoltaic sector experienced notable gains, with stocks like Xinyi Solar and GCL-Poly Energy rising by 7.0% and 9.7%, respectively[6] - Honghua Wisdom Energy reported a 2.0% increase in net profit, contributing to positive investor sentiment[6]

Market Overview - On August 12, the Hong Kong stock market showed a fluctuating trend, with the Hang Seng Index briefly surpassing 25,000 points, ultimately closing up 0.3% at 24,969 points [1] - The Hang Seng Tech Index fell by 0.4%, closing at 5,439 points, with a total market turnover of HKD 215.4 billion [1] - Notable net inflows were seen in the Hong Kong Stock Connect, with the Yingfu Fund and Hang Seng China Enterprises receiving net purchases of approximately HKD 4.16 billion and HKD 1.87 billion, respectively [1] Industry Dynamics Consumer Sector - 361 Degrees (1361 HK) reported a year-on-year revenue increase of 11% and a net profit increase of 8.6% for the first half of the year, aligning with expectations [3] - The company’s gross margin improved to 41.5%, with significant growth in e-commerce revenue by 45% [3] - The management plans to expand its outdoor brand OneWay, currently testing market response with five stores [3] Semiconductor Sector - The semiconductor sector showed strong performance, with stocks like Hongguang Semiconductor (6908 HK) rising by 11.5% and SMIC (981 HK) increasing by over 5% [1][2] - The ongoing U.S.-China trade negotiations, particularly regarding technology and resource exchanges, are expected to impact the semiconductor industry [2] Healthcare Sector - The Hang Seng Healthcare Index fell by 1.0%, but there were no significant negative news affecting the industry [4] - The National Healthcare Security Administration released a preliminary list for the 2025 National Medical Insurance Basic Directory, with a notable increase in the number of drug names passing initial reviews [4] Renewable Energy Sector - The renewable energy and public utility stocks generally rose, although the photovoltaic sector experienced a slight pullback after a previous surge [4] - The price of photovoltaic glass has increased by approximately 7% since the end of July, which may lead to a sustained price increase across the photovoltaic industry [4] Strategic Recommendations - The report suggests focusing on sectors that benefit from policy and industry resonance, including biopharmaceuticals, high-end manufacturing, semiconductors, and AI computing [5][10] - It highlights the importance of structural reforms and the potential for growth in the consumer sector, particularly with the introduction of birth subsidies [10][13] - Specific stock recommendations include Tencent (700 HK), China Unicom (762 HK), and others, indicating a shift from broad market gains to individual stock selection [13]

Market Overview - The Hong Kong stock market is currently in a high-level consolidation phase, with the Hang Seng Index showing a slight increase of 48 points or 0.2%, closing at 24,906 points. The trading volume decreased to 2,009 billion HKD, indicating a rise in cautious sentiment among investors [1][2] - The performance of lithium mining stocks, cement, and paper industries was particularly strong, with Ganfeng Lithium (1772 HK) rising by 20.9% and Tianqi Lithium (9696 HK) increasing by 18.2% [1] Industry Dynamics - The automotive sector led the market gains, with Dongfeng Motor (489 HK) awaiting news on a potential restructuring. Other automotive stocks like Geely (175 HK) and BYD (1211 HK) also saw increases of 2.5% and 0.3%, respectively [3] - The pharmaceutical sector showed stable stock performance, with Innovent Biologics (1801 HK) reporting a strong revenue growth of over 5.2 billion RMB, maintaining a year-on-year increase of over 35% [3] New Energy and Utilities - The new energy sector exhibited mixed performance, with the photovoltaic sector receiving significant market support. Stocks like Xinyi Solar (968 HK) and Flat Glass Group (6865 HK) rose by 5.1% and 3.1%, respectively [4] - Natural gas stocks also saw substantial increases, with Tianlun Gas (1600 HK) rising by 5.5%, driven by expectations of favorable mid-term performance [4] Strategic Insights - The report emphasizes a shift from broad market gains (beta) to individual stock selection (alpha), suggesting a focus on sectors benefiting from structural reforms and policy support, such as semiconductors, AI computing, and the maternal and infant industry [5][8] - The report highlights the importance of the upcoming mid-year earnings reports to validate the market's fundamental outlook, with expectations of increased volatility among sectors [2] Specific Company Focus - Harbin Electric (1133 HK) is identified as a key player in the water power equipment sector, expected to benefit from the launch of the Yarlung Tsangpo River hydropower project, with a projected net profit increase of 95% year-on-year for the first half of 2025 [14] - Hong Kong and China Gas (1083 HK) anticipates moderate growth in natural gas sales, with a projected dividend yield of 4.8% for FY25 [14]

Market Overview - The Hong Kong stock market rebounded last week, with the Hang Seng Index rising 1.4% to close at 24,858 points and the Hang Seng Tech Index increasing 1.2% to 5,460 points. The average daily trading volume decreased by 22.1% week-on-week to over 226.5 billion HKD, while net inflow from the Stock Connect was 21.7 billion HKD. All 12 major sectors in the Hong Kong stock market saw gains, with the materials sector surging 11.0% and the healthcare sector rising only 0.1%, the lowest performer [1]. Earnings Expectations - Current earnings expectations for Hong Kong stocks remain robust, with projected earnings growth rates of 2.7% and 8.5% for 2025 and 2026, respectively. The upstream resources sector benefits from anti-involution policies, coupled with stabilization in the Chinese bond market supporting earnings upgrades. However, short-term valuations have significantly recovered, with the Hang Seng Index's forecast PE returning to mid-range levels of 2018-2019, leading to a high-level consolidation phase in the market [1]. Sector Performance - The automotive sector saw a counter-trend increase last week, with new energy vehicle stocks like Li Auto and NIO rising 1%-3%. Dongfeng Motor surged 22.8% due to domestic anti-involution policies and potential state-owned enterprise restructuring news, outperforming its peers [3]. Industry Dynamics - The environmental, photovoltaic, wind power, natural gas, and electric equipment sectors have shown relative outperformance against the market, with average leads of 1.0%, 2.2%, 0.2%, 17.0%, and 2.2% percentage points, respectively, as of July 31. Conversely, the thermal power, nuclear power, and water supply sectors lagged behind by 0.6%, 6.1%, and 0.5% percentage points, respectively [4]. Power Generation Sector - The thermal power sector is expected to be impacted by rising coal prices, with July coal prices showing a narrowing year-on-year decline. The seasonal increase in coal demand has led to a month-on-month rise in prices, while coal inventories at major ports have decreased [5]. Electric Equipment Sector - The launch of the Yarlung Tsangpo River hydropower project, with a total investment of 1.2 trillion RMB and an expected capacity of 60-70 GW, is anticipated to significantly boost the national hydropower capacity. However, the long construction period may limit short-term profitability for related electric equipment manufacturers, who may face challenges in passing on rising costs to investors [6]. Photovoltaic Sector - As of July 30, the average price of polysilicon rose to 4.94 USD/kg, reflecting a year-on-year increase of 13.3% and a month-on-month increase of 17.1%. In contrast, the average price of photovoltaic modules decreased by 22.4% year-on-year, indicating that downstream demand needs to strengthen to confirm the price increases in polysilicon [7]. Stock Recommendations - Harbin Electric (1133 HK) is positioned to benefit from the Yarlung Tsangpo project, with a projected 95.0% year-on-year increase in net profit for the first half of 2025. Hong Kong and China Gas (1083 HK) expects moderate growth in natural gas sales, with a projected dividend yield of 4.8% for FY25. Cheung Kong Infrastructure (1038 HK) is stable in its operations across public utilities in the UK and Australia/New Zealand, also projecting a 4.8% dividend yield for FY25 [8]. Pharmaceutical Sector - The healthcare sector has shown strong performance, with the Hang Seng Healthcare Index rising 22.8% last month, outperforming the Hang Seng Index by nearly 20 percentage points. Policy support for innovative drug development and successful overseas collaborations for Chinese pharmaceutical companies have contributed to this growth [10]. Policy Developments - The government plans to establish a new directory for innovative drugs and support the use of medical insurance data for drug development, which is expected to enhance the sales of high-priced innovative drugs and accelerate research and development processes [11]. Drug Procurement Policy - The latest drug procurement policy is expected to trend towards moderation, allowing medical institutions to select brands for procurement, which may benefit high-quality products. The new rules aim to ensure that the lowest bids are reasonable and not below cost, thus maintaining the quality of procured drugs [12]. Key Individual Stocks - China Biologic Products (1177 HK) is projected to achieve double-digit growth in product sales revenue for 2025, bolstered by a significant milestone payment from Merck. Haijia Medical (6078 HK) is expected to benefit from the easing of government policies regarding medical insurance, which may improve its operating environment [13].

Market Overview - The Hong Kong stock market has seen a continuous rise for four days, with the Hang Seng Index increasing by 171 points or 0.7%, closing at 25,081 points. The Hang Seng Tech Index rose by 0.3%, closing at 5,546 points. The market turnover exceeded HKD 245.7 billion, with a net inflow of HKD 660 million from the Stock Connect, indicating a significant reduction in net inflow compared to previous days [1] - The trading style of the Stock Connect has shifted from banking, insurance, and pharmaceutical stocks to technology growth stocks led by Tencent and Alibaba, which is beneficial for stabilizing the Hong Kong market [1] - The A-share margin financing and securities lending balance has risen above CNY 2 trillion, reaching a 10-year high, indicating a positive trend in the A-share market and supporting the performance of Hong Kong stocks [1] Macro Dynamics - China's July import and export data exceeded expectations, with exports rising by 7.2% year-on-year, the fastest growth in three months. Exports to the EU and ASEAN increased by 9.2% and 16.6%, respectively, offsetting a 21.7% decline in exports to the US. Imports rose by 4.1% year-on-year, the highest growth since July of the previous year, indicating a recovery in demand [2] Industry Dynamics - The Hang Seng Healthcare Index fell by 2.9%, marking its first decline this week. The US plans to impose tariffs on imported drugs, which negatively impacted companies with overseas expectations. However, the short-term impact on Chinese pharmaceutical companies is limited as their sales are primarily domestic [3] - The performance of the renewable energy and public utility sectors in Hong Kong was mixed, with the photovoltaic sector remaining weak while the wind power sector saw slight increases. Utility companies received support due to their stable business models [3] Industry Strategy - As of July 31, the environmental, photovoltaic, wind power, natural gas, power equipment, and Hong Kong public utility sectors outperformed the market by an average of 1.0%, 2.2%, 0.2%, 17.0%, and 2.2 percentage points, respectively. In contrast, the thermal power, nuclear power, and water supply sectors lagged behind by an average of 0.6%, 6.1%, and 0.5 percentage points [4] Power Generation - The thermal power sector is expected to be impacted by rising coal prices, with July coal prices showing a narrowing year-on-year decline due to seasonal demand increases [5] Power Equipment - The launch of the Yarlung Tsangpo River downstream hydropower project, with a total investment of CNY 1.2 trillion and an expected capacity of 60-70 GW, is anticipated to significantly increase the national hydropower capacity. However, the long construction period may limit short-term profits for equipment manufacturers [6] Photovoltaic Sector - As of July 30, the average price of polysilicon rose by 13.3% year-on-year, while the average price of photovoltaic modules fell by 22.4%. The market is experiencing a divergence between capital market expectations and actual demand in the physical market [7] Stock Recommendations - Harbin Electric (1133 HK) is expected to benefit from the Yarlung Tsangpo project, with a projected 95.0% year-on-year increase in net profit for H1 2025 [8] - Towngas Smart Energy (1083 HK) anticipates moderate growth in natural gas sales, with a projected dividend yield of 4.8% for FY25 [8] - Cheung Kong Infrastructure (1038 HK) operates in stable public utility sectors and is also expected to have a dividend yield of 4.8% for FY25 [8] Pharmaceutical Sector - The healthcare sector has seen significant stock performance, with the Hang Seng Healthcare Index rising by 22.8% in July, outperforming the Hang Seng Index by nearly 20 percentage points. This is attributed to supportive policies for innovative drugs and successful overseas collaborations [10] - The government plans to establish a new directory for innovative drugs and support the use of medical insurance data for drug development, which is expected to enhance the sales of high-priced innovative drugs [11] - The upcoming drug procurement policies are expected to be more moderate, allowing for better quality assurance in the procurement process [12]

Market Overview - On August 6, the Hang Seng Index experienced a slight increase of 0.03%, closing at 24,910 points, with the Hang Seng Tech Index rising by 0.2% to 5,532 points[1] - The total market turnover was HKD 215.2 billion, indicating a gradual decrease in trading activity this week but still maintaining an active level[1] - Net inflow from the Hong Kong Stock Connect was HKD 9.4 billion[1] Sector Performance - The cyclical sectors surged due to "anti-involution" policies, with Morningstar Paper (1812 HK) and Nine Dragons Paper (2689 HK) both rising by 10.8%[1] - Technology stocks showed mixed performance; Tencent (700 HK) rose by 1.7%, while Alibaba (9988 HK) increased by 0.6%, but Meituan (3690 HK) and Baidu (9888 HK) fell[1] - Airline stocks faced significant pressure after Cathay Pacific (293 HK) reported a 9.7% drop in performance[1] Economic Indicators - The U.S. ISM Non-Manufacturing Index unexpectedly fell to 50.1 in July, indicating a slowdown in service sector growth, with new orders showing minimal growth and employment continuing to decline[3] - Rising costs were highlighted, with raw material and service price indicators reaching their highest levels since October 2022, reflecting the impact of tariff uncertainties on supply chains[3] Real Estate Market - In the week ending August 3, the transaction volume of new homes in 30 major cities fell to 161 million square meters, a year-on-year decline of 17.7%[5] - The cumulative transaction volume of new homes in first-tier cities showed a mixed trend, with Beijing down 1.9% and Guangzhou up 14.2% year-on-year[6] Policy Outlook - The Central Political Bureau emphasized the need for sustained macroeconomic policies, including proactive fiscal measures and moderately loose monetary policies, to enhance economic recovery[9] - The real estate sector is expected to benefit from upcoming specific measures aimed at promoting housing demand and inventory reduction[12]

Market Overview - On August 5, the Hong Kong stock market rose for the second consecutive day, with the Hang Seng Index increasing by 169 points or 0.7%, closing at 24,902 points. The Hang Seng Tech Index also rose by 0.7%, closing at 5,521 points. The total market turnover exceeded 229.3 billion HKD, with net inflows from the Stock Connect reaching 23.42 billion HKD [1] - The market structure appears healthy, with most stocks rising, and leading companies in specific sectors performing exceptionally well, surpassing their highs from July 24. Notable performers include Tencent (700 HK), which rose by 1.6% to a new closing high of 559 HKD, and Kuaishou (1024 HK), which increased by 2.8% to also reach a new high for the year [1] - The gaming sector saw record revenue in July, leading to upward revisions in valuations and profit forecasts for major gaming companies like Galaxy Entertainment (27 HK) and Sands China (1928 HK), which rose by 3.5% and 2.6%, respectively [1] Industry Dynamics Consumer Sector - The consumer sector, particularly the hot pot chain Guoquan (2517 HK), reported a 21.6% year-on-year increase in revenue for the first half of the year, with net profit rising by 122.5%. This growth is attributed to an increase in store numbers, improved supply chain efficiency, and expanded online sales channels. The company plans to focus on hot pot condiments and expand its store network in the second half of the year [2] Pharmaceutical Sector - The pharmaceutical sector saw a surge in stock prices for innovative drug companies, with Junshi Biosciences (1877 HK) soaring over 30%. The sector is buoyed by government support for unprofitable tech companies and new pricing mechanisms for innovative drugs. HeYue Pharmaceutical (2256 HK) reported a significant increase in revenue and net profit, driven by licensing fees and the recognition of its drug by both the US FDA and Chinese authorities [3] New Energy and Utilities - The new energy and utilities sector experienced moderate gains, with nuclear power stocks like CGN Mining (1164 HK) and CGN Power (1816 HK) rising by 4.3% and 2.7%, respectively. Thermal power stocks also attracted support despite rising fuel costs expected in the second half of the year [4] Company-Specific Insights WuXi AppTec (2359 HK) - WuXi AppTec reported a 20.6% year-on-year increase in revenue for the first half of 2025, reaching 20.8 billion RMB, with a 44.4% increase in adjusted net profit. The growth is driven by a surge in demand for weight-loss drugs, leading to a 141.6% increase in revenue from its Tides business [10][11] - The company announced its first interim dividend, which is expected to enhance market confidence, with a projected dividend yield of over 35% in 2025 [12] - The target price for WuXi AppTec has been raised to 121.00 HKD, with an upgraded rating to "Buy," reflecting positive adjustments in revenue and profit forecasts for 2025-2027 [13]